Publications by authors named "Udit Verma"

Claim this Profile
C
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
Howard S Hochster, Paul Catalano, Michelle Weitz, Edith P Mitchell, Deirdre Cohen, Udit Verma

J Natl Cancer Inst· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing the Unanticipated: An Uncommon Case of Colorectal Adenocarcinoma Transitioning to Choriocarcinoma - A Case Report and Literature Review.
Hector Garcia Pleitez, Sakditad Saowapa, Diego Olavarria-Bernal, Michel Juarez, Chanakarn Kanitthamniyom, Udit Verma

Eur J Case Rep Intern Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.
Benjamin D Fangman, Suleyman Y Goksu, Nivan Chowattukunnel, Muhammad S Beg, Nina N Sanford, Udit Verma

JCO Oncol Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors.
Suleyman Yasin Goksu, Muhammet Ozer, Muhammad S Beg, Nina Niu Sanford, Chul Ahn, Udit Verma

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.
Megan B Wachsmann, Udit N Verma, Yull E Arriaga, Suntrea T Hammer, Dwight Oliver

J Appl Lab Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
Abdel Nasser Hosein, Huocong Huang, Zhaoning Wang, Kamalpreet Parmar, Wenting Du, Udit Verma

JCI Insight· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Udit Verma

Oncologist· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the Integrity of T Cells from Cancer Patients.
Masato Kobayashi, Jin-Sung Chung, Muhammad Beg, Yull Arriaga, Udit Verma

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?
Jennifer H Stern, Yull Arriaga, Arjun Gupta, Udit Verma, Sirisha Karri

Pancreas· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma.
Jeffrey Meyer, Yull Arriaga, Joselin Anandam, Sirisha Karri, Samira Syed, Udit Verma

Am J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic Mutant Colorectal Adenocarcinoma.
J Randolph Hecht, Al B Benson, Dmitry Vyushkov, Yingsi Yang, Johanna Bendell, Udit Verma

Oncologist· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Jerome C Landry, Yang Feng, Roshan S Prabhu, Steven J Cohen, Charles A Staley, Udit Verma

Oncologist· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Jerome C Landry, Yang Feng, Steven J Cohen, Charles A Staley, Richard Whittington, Udit Verma

Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.
Youn-Tae Kwak, Sofyan M Radaideh, Lianghao Ding, Rui Li, Eugene Frenkel, Udit N Verma

Mol Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between iron deficiency anaemia and serum lipid levels in Indian adults.
Udit Verma, Nilima Shankar, Sri V Madhu, Om P Tandon, Nishi Madan, Neelam Verma

J Indian Med Assoc· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
Weiming Ouyang, Dongyun Zhang, Jingxia Li, Udit N Verma, Max Costa

J Cell Physiol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.
Joe J Stephenson, Charles Gregory, Howard Burris, Tim Larson, Udit Verma

Clin Colorectal Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.
Carlos R Becerra, Udit N Verma, Hia T Tran, Denise Tavana, Noelle S Williams

Am J Clin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil.
Jun Guo, An-wu Zhou, Yu-cai Fu, Udit N Verma, Debu Tripathy

Acta Pharmacol Sin· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation.
Youn-Tae Kwak, Rui Li, Carlos R Becerra, Debu Tripathy, Eugene P Frenkel, Udit N Verma

J Biol Chem· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
Jun Guo, Udit N Verma, Richard B Gaynor, Eugene P Frenkel, Carlos R Becerra

Clin Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity.
Shashi Prajapati, Udit Verma, Yumi Yamamoto, Youn Tae Kwak, Richard B Gaynor

J Biol Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression.
Udit N Verma, Yumi Yamamoto, Shashi Prajapati, Richard B Gaynor

J Biol Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
Yumi Yamamoto, Udit N Verma, Shashi Prajapati, Youn-Tae Kwak, Richard B Gaynor

Nature· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Udit N Verma, Rama M Surabhi, Aurelia Schmaltieg, Carlos Becerra, Richard B Gaynor

Clin Cancer Res· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis